Ponatinib is a multi-targeted tyrosine kinase inhibitor primarily indicated for the treatment of chronic myeloid leukemia. This pharmacological agent functions by inhibiting various receptor tyrosine kinases,… Read more
![Chemical structure of 3,3',3''-(2-(Imidazo[1,2-b]pyridazin-3-ylethynyl)benzene-1,3,5-triyl)triimidazo[1,2-b]pyridazine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F333-2-Imidazo12-bpyridazin-3-ylethynylbenzene-135-triyltriimidazo12-bpyridazine.png&w=3840&q=75)

![Chemical structure of 3,5-bis(Imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F35-bisImidazo12-bpyridazin-3-ylethynyl-4-methyl-N-4-4-methylpiperazin-1-ylmethyl-3-trifluoromethylphenylbenzamide.png&w=3840&q=75)
![Chemical structure of 3-((Trimethylsilyl)ethynyl)imidazo[1,2-b]pyridazine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F943320-60-3-3-Trimethylsilylethynylimidazo12-bpyridazine.png&w=3840&q=75)
![Chemical structure of 3-(Imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-(4-((4-nitrosopiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3-Imidazo12-bpyridazin-3-ylethynyl-4-methyl-N-4-4-nitrosopiperazin-1-ylmethyl-3-trifluoromethylphenylbenzamide.png&w=3840&q=75)
![Chemical structure of 3-(Imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-(4-(piperazin-1-ylmethyl)-3-(trifluoromethyl)phenyl)benzamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F943319-87-7-3-Imidazo12-bpyridazin-3-ylethynyl-4-methyl-N-4-piperazin-1-ylmethyl-3-trifluoromethylphenylbenzamide.png&w=3840&q=75)
![Chemical structure of 3-(Imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methylbenzoic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1300690-48-5-3-Imidazo12-bpyridazin-3-ylethynyl-4-methylbenzoic-Acid.png&w=3840&q=75)

![Chemical structure of 3-Ethynylimidazo[1,2-b]pyridazine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F943320-61-4-3-Ethynylimidazo12-bpyridazine.png&w=3840&q=75)


![Chemical structure of 4-(4-(3-(Imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methylbenzamido)-2-(trifluoromethyl)benzyl)-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)piperazine-1-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F4-4-3-Imidazo12-bpyridazin-3-ylethynyl-4-methylbenzamido-2-trifluoromethylbenzyl-N-4-4-methylpiperazin-1-ylmethyl-3-trifluoromethylphenylpiperazine-1-.png&w=3840&q=75)
![Chemical structure of 7-((Triisopropylsilyl)ethynyl)-3H-imidazo[4,5-b]pyridine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2500888-31-1-7-Triisopropylsilylethynyl-3H-imidazo45-bpyridine.png&w=3840&q=75)
![Chemical structure of Methyl 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methylbenzoate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1356385-96-0-Methyl-3-imidazo12-bpyridazin-3-ylethynyl-4-methylbenzoate.png&w=3840&q=75)

![Chemical structure of N-(4-Formyl-3-(trifluoromethyl)phenyl)-3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methylbenzamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1638193-92-6-N-4-Formyl-3-trifluoromethylphenyl-3-imidazo12-bpyridazin-3-ylethynyl-4-methylbenzamide.png&w=3840&q=75)




Ponatinib is a multi-targeted tyrosine kinase inhibitor primarily indicated for the treatment of chronic myeloid leukemia. This pharmacological agent functions by inhibiting various receptor tyrosine kinases, including BCR-ABL, PDGFR, and c-KIT, to exert its antineoplastic and antiangiogenic effects. This category encompasses a comprehensive collection of Ponatinib reference standards, including pharmacopeial and non-pharmacopeial impurities, metabolites such as glucuronides and nitroso derivatives, and stable isotope-labelled compounds. Pharmaceutical laboratories utilize these materials for robust impurity profiling, method validation, and rigorous quality control protocols. Stable isotope-labelled analogues are particularly essential as internal standards for accurate quantification in complex biological matrices during analytical testing. By providing these essential reference materials, the collection supports the development and maintenance of reliable manufacturing processes, ensuring the efficacy and safety profile of the final drug product in compliance with regulatory standards.